BERNARDO, MARIA ESTER
 Distribuzione geografica
Continente #
EU - Europa 3.865
AS - Asia 3.856
NA - Nord America 3.838
SA - Sud America 996
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 83
OC - Oceania 10
Totale 12.868
Nazione #
US - Stati Uniti d'America 3.552
RU - Federazione Russa 1.988
SG - Singapore 1.452
CN - Cina 1.183
BR - Brasile 820
IT - Italia 709
SE - Svezia 468
HK - Hong Kong 459
VN - Vietnam 359
FR - Francia 178
DE - Germania 131
CA - Canada 117
BD - Bangladesh 108
GB - Regno Unito 101
AR - Argentina 74
IN - India 65
NL - Olanda 60
FI - Finlandia 58
ID - Indonesia 43
AT - Austria 42
MX - Messico 41
CR - Costa Rica 35
PL - Polonia 34
EC - Ecuador 31
IQ - Iraq 27
ZA - Sudafrica 26
JP - Giappone 23
TR - Turchia 20
UA - Ucraina 18
CO - Colombia 17
SA - Arabia Saudita 17
VE - Venezuela 17
ES - Italia 15
GT - Guatemala 15
MY - Malesia 15
UZ - Uzbekistan 14
LT - Lituania 13
SV - El Salvador 13
HN - Honduras 12
MA - Marocco 12
EG - Egitto 11
JM - Giamaica 11
KE - Kenya 11
NP - Nepal 11
PY - Paraguay 11
TT - Trinidad e Tobago 11
IL - Israele 9
BE - Belgio 8
NI - Nicaragua 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CL - Cile 7
DO - Repubblica Dominicana 7
IE - Irlanda 7
MD - Moldavia 7
PE - Perù 7
UY - Uruguay 7
GP - Guadalupe 6
JO - Giordania 6
PK - Pakistan 6
PR - Porto Rico 6
RO - Romania 6
DZ - Algeria 5
IR - Iran 5
AU - Australia 4
CZ - Repubblica Ceca 4
EU - Europa 4
TN - Tunisia 4
BO - Bolivia 3
EE - Estonia 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
KR - Corea 2
MT - Malta 2
NG - Nigeria 2
PT - Portogallo 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
DK - Danimarca 1
FJ - Figi 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
Totale 12.638
Città #
Singapore 553
Ashburn 506
Moscow 475
Hong Kong 459
San Jose 397
Dallas 356
Shanghai 242
Milan 222
Council Bluffs 191
Beijing 164
Hefei 161
Lauterbourg 139
Lawrence 138
Princeton 138
New York 129
Ho Chi Minh City 126
Santa Clara 98
Los Angeles 86
Hanoi 80
São Paulo 66
Phoenix 44
Rome 42
Helsinki 37
Boardman 33
Montreal 29
Nuremberg 29
Orem 29
Miano 27
Dronten 26
Rio de Janeiro 25
London 24
San José 24
Warsaw 24
Atlanta 23
Brooklyn 23
Chicago 22
Guangzhou 22
Haiphong 22
Munich 22
Naples 22
North Bergen 22
Frankfurt am Main 20
Houston 20
Toronto 20
Chennai 19
Curitiba 18
San Francisco 17
Tokyo 17
Denver 16
Johannesburg 16
Brasília 15
Washington 15
Boston 14
Brescia 14
Da Nang 14
Mexico City 14
Shenzhen 14
Tashkent 14
Buffalo 13
Guarulhos 13
Las Vegas 13
Poplar 13
San Salvador 13
Turku 13
Vienna 13
Cesano Boscone 12
Guayaquil 12
San Diego 12
Seattle 12
Stockholm 12
Turin 12
Hangzhou 11
Hải Dương 11
Monza 11
Porto Alegre 11
Belo Horizonte 10
Columbus 10
Memphis 10
Mumbai 10
Nairobi 10
Palermo 10
Philadelphia 10
Salvador 10
Kuala Lumpur 9
The Dalles 9
Baghdad 8
Cumming 8
Florence 8
Genoa 8
Jacksonville 8
Lappeenranta 8
Managua 8
Manchester 8
Miami 8
Recife 8
Ankara 7
Bari 7
Boydton 7
Charlotte 7
Dhaka 7
Totale 5.994
Nome #
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 264
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 225
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 169
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 166
A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB 165
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease 158
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 150
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 149
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 141
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 137
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art 135
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 134
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 134
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 132
Access to gene therapy for rare diseases when commercialization is not fit for purpose 127
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 125
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 124
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 124
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 118
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 117
Assessment of human herpesvirus-6 infection in mesenchymal stromal cells ex vivo expanded for clinical use 116
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 115
Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies 114
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 111
A new enzyme-linked immunosorbent assay for a total anti-T lymphocyte globulin determination: Development, analytical validation, and clinical applications 108
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 108
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fatal calf serum substitute 104
Bone Marrow-Derived Mesenchymal Stromal Cell Intra-Fistular Injections Induce An Up-Regulation Of Foxp3+ Regulatory T-Cells In Patients With Crohn’s Disease 103
Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan 103
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 102
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia 102
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 99
Haematopoietic stem cell gene therapy in inborn errors of metabolism 97
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 97
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease 96
A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation 96
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. 96
Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System 95
Bone marrow-derived mesenchymal stromal cells (MSC) locally injected for refractory fistulizing Crohn’s disease modulate immunoglobulin production 94
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas 94
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity 94
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 93
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. 92
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: Disorders due to secondary impairment of RUNX1 and MPL genes 92
Cannabinoid receptor 2 as antiobesity target: Inflammation, fat storage, and browning modulation 89
Mesenchymal stromal cells: A novel treatment modality for tissue repair 86
Cord blood transplantation in childhood 84
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome 83
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 83
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 82
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 81
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells 81
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects 79
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia 78
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia 77
How I treat relapsed childhood acute lymphoblastic leukemia 75
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study 75
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial 75
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes 75
The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy 74
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 74
Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors 74
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 73
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders 73
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 73
Ex vivo expansion of mesenchymal stromal cells 73
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 73
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation 72
Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation 71
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 71
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 70
Effects Of Bone Marrow-Derived Mesenchymal Stromal Cells Infused In Fistulas Of Patients With Perianal Crohn’s Disease On Serum Cytokine Pattern, Salivary Iga Production, And Circulating Lymphocyte Subsets 70
Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism 69
MSCs in Pediatric Hematopoietic Stem Cell Transplantation (Chapter 26) 69
Bone marrow-derived mesenchymal stromal cells locally injected for refractory fistulizing Crohn’s disease modulate serum immunoglobulins, secretory IgA, and antibody production 69
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms 69
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar) 68
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I 67
Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centers 66
Cord blood transplantation in children with haematological malignancies 66
Mesenchymal stromal cells and chronic inflammatory bowel disease 66
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation 66
Gene therapy for mucopolysaccharidoses: In vivo and ex vivo approaches 10 Technology 1004 Medical Biotechnology 65
Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? 65
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation 65
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 64
Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system 64
Low percentages of circulating CD8+/CD45RA+ human T lymphocytes expressing β7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 64
Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation 64
Successful treatment of fistulizing crohn's disease with local infusions of autologous bone marrow-derived mesenchymal stem cells 63
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 63
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources 62
Hematopoietic stem cell gene therapy of neurometabolic lysosomal storage diseases 61
Treatment of fistulizing Crohn’s disease with local infusions of autologus bone marrow-derived mesenchymal stromal cells 61
Mesenchymal stromal cells: Sensors and switchers of inflammation 61
ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications 60
Human Bone Marrow-Derived Mesenchymal Stromal Cells Reduce the Severity of Experimental Necrotizing Enterocolitis in a Concentration-Dependent Manner 60
Transgenic expression of IL-10 by lentiviral vectors for increasing the anti-inflammatory efficacy of mesenchymal stromal cells 60
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 60
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders 59
Totale 9.355
Categoria #
all - tutte 77.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 43 4 7 4 3 15 1 4 4
2022/2023866 313 147 47 4 31 124 13 31 97 6 36 17
2023/2024435 20 23 30 47 36 45 84 32 3 12 31 72
2024/20252.409 317 48 99 36 67 154 253 209 449 325 228 224
2025/20267.033 472 583 479 1.072 491 198 571 489 1.801 348 239 290
2026/20271.934 236 473 409 816 0 0 0 0 0 0 0 0
Totale 12.868